Harbor Multi asset Explorer ETF (MAPP) Quote

And a purchase tomorrow will cost you $0.05….attractiveness for a new investor.

Sure most of us have cost basis higher than $0.05 or $0.10 but that is irrelevant to what happens tomorrow. Lack of current volume and enthusiasm is the problem as you have said so many times.

FDA submission? Haven't seen anything about that. EMA? This year? I'll believe it when I see it.

Excellent!!! Thanks for the great news. :-)

I don’t think he is, in the sense that the results are encouraging for a new P3 trial designed to iron out the titration difficulties and with a larger n that includes ethnic diversity.

Qrtly after closing on Friday…. eom

To think JD Davis was the cleanup hitter just a few games ago.

I can't tell without hearing his words at the presentation (especially whether an explanation for all the missing data was stated. He did not prepare the company slides.

Vulgarity will get you nowhereLOL says you.

And you’re still replying.. Huh.. I think Chartman has a question for you.

"There they"--Both will eat their words !!!!! Losers !!!!

LOL. BLOCK

Thank you for the link. Yes, as expected, the safety cohort n is any patient receiving one dose (hence 335 pooled). The mITT would be the n on top of slide 11 (and used in the MMRM/LSM analysis), the numbers at 48 weeks for ADAS-Cog (slide 13) are the protocol completers (lots of dropout) and onl

Ok understood the tactic of lowering expectations to avoid disappointment. You seem not have followed what’s been going on EMA and FDA submissions lately. Catch them up!

Some of the positive comments, especially about Ocrevus ('We expect that Ocrevus subcut represents an incremental CHF2 billion in sales opportunity and we expect this to be increasingly visible in the coming quarters as we are already starting to see some strong pickup in our very early launch count

They have the full funding and have been open with all of their communications here lately. This has the markings of a Snow White OTC and then some here. i.m.o

You seem to have forgotten that approval is secured is no input from FDA in 30 calendar days. Because of that if no input on 30th day, whether a weekend or holiday, than approval can be assumed.

Still at 8:56, that helps.
"Global surge in benevolence".
Good music fits.
Some of my best work fo sho ;).
Two year back. 2022 and the rest
there helluva link too.
"ambition idealistic = moral ambition, do it "
If only could recall a decent percent

Unfortunately Anavex clinical trial outcome news always raises questions, which is why the price of $AVXL tend to move opposite of WGT expectations.

This time is no different.

GTCH Thank you as always for posting. Please post a link to the 6/18/24 filing. I am clearly not as adept as you in Google searching.

GetSeriousOK - Thought you surrendered: "you can do so with no more comments from me" - 7/18/24. Another lie?

thanks for posting more confirmation

🔴🔴Whistleblower FOUND for CITADEL AMC algo?:

*** Click on images to zoom? (if needed?) ***

https://investorshub.advfn.com/uimage/uploads/2024/7/12/ktnzuAMC_ALGO2.png

https:

What shorts?
From OTCM:
Short Interest
1,000

(pls don’t come back with bogus “short volume” data from the click-bait site OTCShortreport).